Carsten Kötting

Carsten Kötting

Auto-generated profile, based on publicly available information

Carsten Kötting

Center for Protein Diagnostics (PRODI), Biospectroscopy, Ruhr University Bochum, Bochum, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2004 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
MKMarco Klähn
Marco Klähn
GMGerald Mathias
Gerald Mathias
CKCarsten Kötting
Carsten Kötting
MNMarco Nonella
Marco Nonella
JSJürgen Schlitter
Jürgen Schlitter
PTPaul Tavan
Paul Tavan

20 December 2013 in The Analyst
Verified
Journal Article
Closed access
PDF file
SESamir F. El-Mashtoly
Samir F. El-Mashtoly
DPDennis Petersen
Dennis Petersen
HYHesham K. Yosef
Hesham K. Yosef
AMAxel Mosig
Axel Mosig
ARAnke Reinacher-Schick
Anke Reinacher-Schick
KGKlaus Gerwert
Klaus Gerwert
Targeted cancer therapies block cancer growth and spread using small molecules. Many molecular targets for an epidermal growth factor receptor (EGFR) selectively compete with the adenosine triphosphate-binding site of its tyrosine kinase domain. Detection of molecular targeted agents and their metabolites in cells/tissues by label-free imaging is attractive because dyes or fluorescent labels may be toxic or invasive. Here, label-free Raman microscopy is applied to show the spatial distribution of the molecular targeted drug erlotinib within the cell. The Raman images show that the drug is clustered at the EGFR protein at the membrane and induces receptor internalization. The changes within the Raman spectrum of erlotinib measured in cells as compared to the free-erlotinib spectrum indicate that erlotinib is metabolized within cells to its demethylated derivative. This study provides detailed insights into the drug targeting mechanism at the atomic level in cells. It demonstrates that Raman microscopy will open avenues as a non-invasive and label-free technique to investigate pharmacokinetics at the highest possible resolution in living cells.

1 October 2012 in Biophysical Journal
Verified
Journal Article
Closed access
JGJörn Güldenhaupt
Jörn Güldenhaupt
TRTill Rudack
Till Rudack
PBPeter Bachler
Peter Bachler
DMDaniel Mann
Daniel Mann
GTGemma Triola
Gemma Triola
KGKlaus Gerwert
Klaus Gerwert

22 April 2005 in Chemphyschem
Verified
Journal Article
Closed access
PDF file
CKCarsten Kötting
Carsten Kötting
KGKlaus Gerwert
Klaus Gerwert

16 February 2016 in Analytical Chemistry
Verified
Journal Article
Closed access
ANAndreas Nabers
Andreas Nabers
JOJulian Ollesch
Julian Ollesch
JSJonas Schartner
Jonas Schartner
CKCarsten Kötting
Carsten Kötting
JGJust Genius
Just Genius
JWJens Wiltfang
Jens Wiltfang

29 April 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CKCarsten Kötting
Carsten Kötting
AKAngela Kallenbach
Angela Kallenbach
YSYan Suveyzdis
Yan Suveyzdis
AWAlfred Wittinghofer
Alfred Wittinghofer
KGKlaus Gerwert
Klaus Gerwert
Members of the Ras superfamily of small G proteins play key roles in signal transduction pathways, which they control by GTP hydrolysis. They are regulated by GTPase activating proteins (GAPs). Mutations that prevent hydrolysis cause severe diseases including cancer. A highly conserved “arginine finger” of GAP is a key residue. Here, we monitor the GTPase reaction of the Ras·RasGAP complex at high temporal and spatial resolution by time-resolved FTIR spectroscopy at 260 K. After triggering the reaction, we observe as the first step a movement of the switch-I region of Ras from the nonsignaling “off” to the signaling “on” state with a rate of 3 s −1 . The next step is the movement of the “arginine finger” into the active site of Ras with a rate of k 2 = 0.8 s −1 . Once the arginine points into the binding pocket, cleavage of GTP is fast and the protein-bound P i intermediate forms. The switch-I reversal to the “off” state, the release of P i , and the movement of arginine back into an aqueous environment is observed simultaneously with k 3 = 0.1 s −1 , the rate-limiting step. Arrhenius plots for the partial reactions show that the activation energy for the cleavage reaction is lowered by favorable positive activation entropy. This seems to indicate that protein-bound structured water molecules are pushed by the “arginine finger” movement out of the binding pocket into the bulk water. The proposed mechanism shows how the high activation barrier for phosphoryl transfer can be reduced by splitting into partial reactions separated by a P i -intermediate.